{"id":63003,"date":"2026-04-25T04:02:20","date_gmt":"2026-04-25T02:02:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/"},"modified":"2026-04-25T04:02:20","modified_gmt":"2026-04-25T02:02:20","slug":"integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/","title":{"rendered":"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing"},"content":{"rendered":"
\n

SYDNEY–(BUSINESS WIRE)–#AI<\/a>–Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction.<\/p>\n

<\/a>
<\/a><\/p>\n

\nSince initiating the Series A, Integrant has achieved a series of technical milestones, including meaningful progress in the development of its artificial intelligence platform. Considering both the capital secured and these advancements, the company has reassessed its funding strategy. Management has determined that the original allocation framework established at the outset of the Series A is no longer aligned with current priorities and opportunities.<\/p>\n

\nWith the company currently targeting an initial public offering (IPO) in approximately seven months, Integrant is actively exploring a pre-IPO placement. This prospective round is intended to provide an opportunity for investors who were unable to participate in the Series A to engage with the company ahead of a potential public listing.<\/p>\n

\nThe pre-IPO raise is expected to support final-stage development, operational scaling, and market readiness initiatives as Integrant continues preparations for its targeted Nasdaq listing.<\/p>\n

\nInvestors seeking further information regarding the anticipated IPO or pre-IPO participation are encouraged to make direct contact with the company.<\/p>\n

\nAbout Integrant<\/b><\/p>\n

\nIntegrant is a technology company developing integrated solutions across artificial intelligence, medical technology and biologics.<\/p>\n

\nForward-Looking Statements<\/b><\/p>\n

\nThis press release contains forward-looking statements, including statements regarding the proposed IPO and future fundraising activities. These statements are subject to risks and uncertainties, and actual results may differ materially. Integrant undertakes no obligation to update forward-looking statements, except as required by applicable law.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Adelaide Slater
\n
Integrant Pty Ltd
\n
Phone: +61 439 880 233
\n
Email: media@integrant.com.au<\/a>
Website: www.integrant.com.au<\/a>
Investment Contact:<\/b>
Email: Investor_relations@integrant.com.au<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SYDNEY–(BUSINESS WIRE)–#AI–Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction. Since initiating the Series A, Integrant has achieved … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63003","6":"format-standard","7":"category-industry"},"yoast_head":"\nIntegrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SYDNEY–(BUSINESS WIRE)–#AI–Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction. Since initiating the Series A, Integrant has achieved ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-25T02:02:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260422882502\/en\/2781851\/22\/Integrant_Logo_Black_Background.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing\",\"datePublished\":\"2026-04-25T02:02:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/\"},\"wordCount\":315,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260422882502\\\/en\\\/2781851\\\/22\\\/Integrant_Logo_Black_Background.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/\",\"name\":\"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260422882502\\\/en\\\/2781851\\\/22\\\/Integrant_Logo_Black_Background.jpg\",\"datePublished\":\"2026-04-25T02:02:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260422882502\\\/en\\\/2781851\\\/22\\\/Integrant_Logo_Black_Background.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260422882502\\\/en\\\/2781851\\\/22\\\/Integrant_Logo_Black_Background.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/","og_locale":"en_US","og_type":"article","og_title":"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing - Pharma Trend","og_description":"SYDNEY–(BUSINESS WIRE)–#AI–Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction. Since initiating the Series A, Integrant has achieved ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-25T02:02:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260422882502\/en\/2781851\/22\/Integrant_Logo_Black_Background.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing","datePublished":"2026-04-25T02:02:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/"},"wordCount":315,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260422882502\/en\/2781851\/22\/Integrant_Logo_Black_Background.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/","url":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/","name":"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260422882502\/en\/2781851\/22\/Integrant_Logo_Black_Background.jpg","datePublished":"2026-04-25T02:02:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260422882502\/en\/2781851\/22\/Integrant_Logo_Black_Background.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260422882502\/en\/2781851\/22\/Integrant_Logo_Black_Background.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/integrant-announces-closure-of-series-a-capital-raise-now-exploring-pre-ipo-raise-ahead-of-november-listing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63003"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63003\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}